-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Arbidol Capsules Selected as a “Landmark Achievement in Chinese Pharmaceutical Science and Technology” Commemorating the 70th Anniversary of the Founding of the People’s Republic of China
Category:
发布时间：2019-11-05
【概要描述】
From November 4 to 7, 2019, the “2019 National Pharmaceutical Economic Information Release Conference and Mifang Association Annual Meeting,” guided by the Chinese Pharmacists Association, the China Over-the-Counter Drugs Association, and the China Medical Education Association and organized by the Pharmaceutical Economics Daily and Biaodian Information (Group), was grandly held at the Baiyun International Convention Center in Guangzhou, Guangdong Province.
From November 4 to 7, 2019, the “2019 National Pharmaceutical Economic Information Release Conference and Mifang Conference Annual Meeting,” guided by the Chinese Pharmacists Association, the China Over-the-Counter Drugs Association, and the China Medical Education Association and organized by the Pharmaceutical Economics Daily and Biaodian Information (Group), was grandly held at the Baiyun International Convention Center in Guangzhou, Guangdong Province.
To trace the glorious 70-year journey of New China through the pharmaceutical industry and to showcase the historic transformations and achievements of the sector since the founding of the People’s Republic, the conference solemnly launched the “A Tribute to 70 Years of Glorious Achievements—A Tour of Pharmaceutical Industry Milestones Commemorating the 70th Anniversary of the Founding of New China” initiative. This initiative honors industry leaders, rallies momentum for industrial upgrading, and drives innovation and development across the sector. Notably, the company’s product, Arbidol Hydrochloride Capsules, was successfully selected as a “Landmark Achievement in Chinese Pharmaceutical Science and Technology.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091